Medigrex SA
4.8 FTEThe score of Medigrex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -14 % Total assets +29 % Headcount (avg FTE) +9 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medigrex's annual accounts
| 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 198,059 € | ||||
| Equity | 535,052 € | ||||
| Cash | 414,934 € | ||||
| EBITDA | 303,500 € | ||||
| Total assets | €1.18m |
Filed annual accounts
- Year ended 30 Sep 2025filed on 27 Apr 2026
- Year ended 30 Sep 2024filed on 24 Apr 2025
- Year ended 30 Sep 2023filed on 19 Mar 2024
- Year ended 30 Sep 2021filed on 26 Apr 2022
- Year ended 30 Sep 2020filed on 26 Apr 2021
Medigrex's financial analysis
- Solvency45.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medigrex
Medigrex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.660.871
- VAT number
- BE0465660871
- Peppol
- Registered · 0208:0465660871 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Mar 1999
- Registered office
- 2990 Wuustwezel
- Size
- Micro · 4.8 FTE
- Latest accounts
- 2025 · filed on 27 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medigrex (SA) has been based in Wuustwezel since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 198,059 € and equity of 535,052 €; its revenue is not published. With 4.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 45.2%, above the median of its sector (44.2%).
Companies similar to Medigrex
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Andromede Retail sale of pharmaceutical products Frameries · balance sheet €1.18m
- MPL Pharma Retail sale of pharmaceutical products Ciney · balance sheet €1.05m
- DE Apotheek Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet €1.18m
- Brugafar Retail sale of pharmaceutical products Nieuwpoort · balance sheet €1.18m
- Pharmaphie SDW Retail sale of pharmaceutical products Ghent · balance sheet €1.19m
- Apotheke Schunck Retail sale of pharmaceutical products Eupen · balance sheet €1.18m
- Zellik Pharma Retail sale of pharmaceutical products Asse · balance sheet €1.25m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
Frequently asked questions about Medigrex
What is the revenue of Medigrex?
Medigrex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medigrex?
In Belgium, the VAT number is the company number prefixed with BE: BE0465660871 for Medigrex, if the company is VAT-registered. Its company number (CBE) is 0465.660.871.
Where is the registered office of Medigrex?
According to the CBE register, the registered office of Medigrex is in 2990 Wuustwezel.
What is the equity of Medigrex?
At the close of the 2025 financial year, the equity of Medigrex amounts to 535,052 €, a solvency of 45.2% of total assets.
How many people work at Medigrex?
4.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Medigrex?
The register lists 2 active mandates at Medigrex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medigrex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →